Friday, January 1, 2010
Privacy Policy
If you require any more information or have any questions about our privacy policy, please feel free to contact us by email at tyo.goteh@gmail.com.
At http://a-diabetesmellitus.blogspot.com/, the privacy of our visitors is of extreme importance to us. This privacy policy document outlines the types of personal information is received and collected by http://a-diabetesmellitus.blogspot.com/ and how it is used.
Log Files
Like many other Web sites, http://a-diabetesmellitus.blogspot.com/ makes use of log files. The information inside the log files includes internet protocol ( IP ) addresses, type of browser, Internet Service Provider ( ISP ), date/time stamp, referring/exit pages, and number of clicks to analyze trends, administer the site, track user’s movement around the site, and gather demographic information. IP addresses, and other such information are not linked to any information that is personally identifiable.
Cookies and Web Beacons
http://a-diabetesmellitus.blogspot.com/ does use cookies to store information about visitors preferences, record user-specific information on which pages the user access or visit, customize Web page content based on visitors browser type or other information that the visitor sends via their browser.
DoubleClick DART Cookie
.:: Google, as a third party vendor, uses cookies to serve ads on http://a-diabetesmellitus.blogspot.com/.
.:: Google's use of the DART cookie enables it to serve ads to users based on their visit to http://a-diabetesmellitus.blogspot.com/ and other sites on the Internet.
.:: Users may opt out of the use of the DART cookie by visiting the Google ad and content network privacy policy at the following URL - http://www.google.com/privacy_ads.html
Some of our advertising partners may use cookies and web beacons on our site. Our advertising partners include ....
Google Adsense
Commission Junction
Widget Bucks
Adbrite
Clickbank
Azoogle
Chitika
Linkshare
Amazon
Kontera
These third-party ad servers or ad networks use technology to the advertisements and links that appear on http://a-diabetesmellitus.blogspot.com/ send directly to your browsers. They automatically receive your IP address when this occurs. Other technologies ( such as cookies, JavaScript, or Web Beacons ) may also be used by the third-party ad networks to measure the effectiveness of their advertisements and / or to personalize the advertising content that you see.
http://a-diabetesmellitus.blogspot.com/ has no access to or control over these cookies that are used by third-party advertisers.
You should consult the respective privacy policies of these third-party ad servers for more detailed information on their practices as well as for instructions about how to opt-out of certain practices. http://a-diabetesmellitus.blogspot.com/'s privacy policy does not apply to, and we cannot control the activities of, such other advertisers or web sites.
If you wish to disable cookies, you may do so through your individual browser options. More detailed information about cookie management with specific web browsers can be found at the browsers' respective websites.
Sunday, February 1, 2009
Diabetes mellitus (contents)
- What is diabetes mellitus?
- Clinical presentation of diabetes
- Types of diabetes
- What is pre-diabetic state?
- Maturity onset dibetes of young adults
- Epidemiology of diabetes
- Nutrition of diabetes
- Ayurveda remedy for diabetes mellitus
- Bitter gourd remedy for diabetes mellitus
Type 1 Diabetes mellitus
- Type 1 diabetes mellitus
- Clinical features of type 1 dm
- Investigations for type1 dm
- Overview of management of type 1 dm
- Medication for type 1 dm
- Follow up plan for type 1dm
Type 2 Diabetes mellitus
- Type 2 diabetes mellitus
- Clinical features of type 2 dm
- Investigations for type2 dm
- Overview of management of type 2 dm
- Medication for type 2 dm
- Follow up plan for type 2 dm
Diabetes and pregnancy
- Diabetes and pregnancy
- Fetal abnormalities/problems (morbidity) with diabetes during pregnancy
- Maternal problems (morbidity) associated with diabetes during pregnancy
- Perinatal morbidities and birth injuries associated with pregnancies complicated with diabetes
- Investigations of diabetes during pregnancy
- Diagnosing diabetes during pregnancy
- Peripartal management of patients and fetuses with diabetes
- Pregnancy management of women with gestational diabetes (GDM)
- Pregnancy management of women with preexisting diabetes
- Insulin therapy for pregnant mothers with diabetes
- Medical Care for pregnancies complicated with diabetes
- Timing and route of delivery for pregnancies with diabetes.
- Screening for diabetes during pregnancy
- Follow up of diabetes mothers following delivery
- Medicolegal Pitfalls and diabetes in pregnancies
Investigations
- Laboratory tests for Screening and Diagnosis of diabetes mellitus
- Glucose tolerance test
- Glycosylated Hemoglobin (HbA1C)
Oral antidiabetic drugs
Insulin
Diabetic emergencies
Complications of diabetes
- Complications of diabetes mellitus
- Diabetic Nephropathy
- Diabetic neuropathy
- Diabetic Retinopathy
- DIABETIC FOOT
- Management of diabetic foot diseases
- erectile dysfunction
Diabetes insipidus
Erectile dysfunction and diabetes
Diabetes and other conditions
New developments
SearchMotron.com
What is diabetes mellitus?
There are four types of diabetes;
- Type 1 diabetes mellitus ( due to lack of insulin)
- Type 2 diabetes mellitus (due to increased resistence to insulin)
- Type 3 diabetes mellitus ( secondary to other illness)
- Type 4 diabetes mellitus (diabets mellitus during pregnancy)
What are the types of diabetes mellitus?
Diabetes is a metabolic disease characterized by hyperglycemia resulting from defects in insulin secretion or insulin action or both.
TYPES OF DIABETES
There are four types of diabetes.
1. Type 1 diabetes.
2. Type 2 diabetes.
3. Diabetes secondary to other diseases
4. Diabetes during pregnancy.
Type 1 diabetes
Type 1 diabetes is common among younger people especially children. But it can affect any age group.
Latent Autoimmune Diabetes of Adults (LADA) is a variant of type 1 diabetes but it is difficult to distinguish from type 2 diabetes mellitus.
Type 2 diabetes
This is the commonest form of diabetes and it carries a significant risk of morbidities and mortalities. 90-95% of patients with diabetes belong to this category. This condition is due to the resistance to insulin. But sometime it can be due to the lack of insulin or both. Majority of patients are middle or older age group.
Diabetes secondary to other diseases
1-2% of diabetes patients belong to this group. This condition can be cured if the underlying cause is identified. This can be due to liver disorders, pancreatic disorders, other endocrinopathies or drug induced.
Diabetes during pregnancy (gestational diabetes mellitus).
This is a special category and it occurs during pregnancy and disappears after the delivery. But it is a real burden for the patient and doctors as it can be difficult to control. Obesity, family history of diabetes and past history of gestational diabetes are some risk factors.
Clinical presentation of diabetes mellitus
- asymptomatic( incidental finding)
- presentation with acute symptoms
- subacute presentation
- presentation with complications

Asymptomatic presentation
This is the commonest presentation and it is an incidental finding during routine examination or medical examination for insurance/ license/ employment
There is no evidence of ill health
Elevated blood sugar level could be a finding at those routine examinations. There can be glucose in the urine as well, even though it is a clue of hyperglycemia, not diagnostic
Further investigations should be done
Acute presentation
Usually these patients present with classic triad of symptoms;
- polyuria
- polydipsia
- weight loss
They have a brief history (2-6 weeks)
Usually patients with type 2 diabetes present like this
Subacute presentation
These patients have symptoms over a period of months or years. Common symptoms are polyuria, polydipsia, and weight loss.
They can also present with non-specific symptoms such as:
- lack of energy
- visual blurring
- pruritus vulvae
- balanitis
This is the usual presentation of type 2 diabetes mellitus.
Presentation with complications
Types of complications are;
1. microvascular
2. macrovascular
3. others
Microvascular complications;
1. nephropathy
2. neuropathy
3. retinopathy
Macrovascular complications;
1. Ischemic heart disease
2. stroke
3. peripheral vascular disease
Others;
1. staphylococcal skin infections (furuncles, carbuncles, abscesses)
2. wound infections
What is pre-diabetes?
Pre-diabetes is a condition that comes before type 2 diabetes. Blood glucose (sugar) levels are higher than normal but aren’t high enough to be called diabetes. Pre-diabetes is a silent disease, meaning you can have it but not know it. By reducing the calorie intake, being physically active and loosing weight can delay the type 2 diabetes mellitus.
Prevention of type 2 diabetes mellitus
People with risk factors should be identified and they should be educated on how to reduce those risk factors.
Cut down calorie intake
Stop smoking
Exercise about 30 minutes per day
Loosing weight
People who are at risks;
You’re at risk for diabetes if you
- are overweight
- are physically inactive
- have a parent, brother, or sister with diabetes
- are African American, Native American, Asian American, Pacific Islander, or Hispanic American
- have had a baby weighing more than 9 pounds or have had gestational diabetes
- have high blood pressure (over 140/90 mmHg)
- have low HDL cholesterol (35 mg/dl or lower)
- or high triglycerides (250 mg/dl or higher)
Investigations
It does not have any symptoms therefore people with risk factors should undergo investigations.
1. fasting blood glucose
Pre-diabetes is diagnosed when fasting glucose levels are between 100 and 125 mg/dl. A fasting plasma glucose of 126 mg/dl or higher means diabetes.
2. oral glucose tolerance test
Pre-diabetes is diagnosed when blood glucose is between 140 and 199 mg/dl 2 hours after drinking glucose drink. These glucose levels are above normal but not high enough to be called diabetes. A 2-hour blood glucose of 200 mg/dl or higher means diabetes.
Treatment
There are no drugs to be effective in this condition. Only measures that patient should take is reduction of risk factors and undergoing regular assessments.
Maturity onset Diabetes of the Young (MODY)
Maturity onset diabetes of the young (MODY) is a subtype of DM. It is characterized by autosomal dominant inheritance, early onset of hyperglycemia, and impairment in insulin secretion. Several monogenic forms of DM have been identified.
1. MODY 1
2. MODY 2
3. MODY 3
4. MODY 4
5. MODY 5
6. MODY 6
The glucokinase gene is intimately involved in the glucose-sensing mechanism within the pancreatic beta-cell. The hepatic nuclear factor (HNF) genes and the insulin promoter factor-1 (IPF-1) gene control nuclear transcription in the beta-cell where they regulate its development and function. Abnormal nuclear transcription genes may cause pancreatic agenesis or more subtle progressive pancreatic damage
MODY 1
This is caused by mutations in the hepatocyte nuclear transcription factors (HNF) 4a.
| Chromosomal location | 20q |
| Proportion of all MODY cases | 5% |
| Onset | Teens to thirties |
| Progression | Progressive hyperglycemia |
| Microvascular complications | Frequent |
| Other features | None |
MODY 2
MODY 2 is the result of mutations in the glucokinase gene that lead to mild-to-moderate hyperglycemia. Glucokinase catalyzes the formation of glucose-6-phosphate from glucose.
| Chromosomal location | 7q |
| Proportion of all MODY cases | 15% |
| Onset | Present from birth |
| Progression | Little deterioration with age |
| Microvascular complications | Rare |
| Other features | Reduced birthweight |
MODY 3
This is caused by mutations in the hepatocyte nuclear transcription factors (HNF) 1a.
| Chromosomal location | 12q |
| Proportion of all MODY cases | 12q |
| Onset | teens/twenties |
| Progression | Progressive hyperglycemia |
| Microvascular complications | frequent |
| Other features | sensitive to sulphonylurea |
MODY 4
This is a rare variant caused by mutations in the insulin promoter factor (IPF) 1, which is a transcription factor that regulates pancreatic development and insulin gene transcription.
| Chromosomal location | 13q |
| Proportion of all MODY cases | <1% |
| Onset | teens to thirties |
| Progression | Progression unclear |
| Microvascular complications | few data |
| Other features | Pancreatic agenesis in homozygotes |
MODY 5
This is caused by mutations in the hepatocyte nuclear transcription factors (HNF) 1b.
| Chromosomal location | 17q |
| Proportion of all MODY cases | 2% |
| Onset | Teens/twenties |
| Progression | Progression unclear |
| Microvascular complications | Frequent |
| Other features | Renal cysts, Proteinuria, Renal failure |
MODY 6
This is due to the mutation in the neurogenic differention factor1 (NeuroD1)
| Chromosomal location | 2q |
| Proportion of all MODY cases | <7% |
| Onset | |
| Progression | |
| Microvascular complications | |
| Other features |

